BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 11053642)

  • 1. In vivo gene expression profile analysis of metallothionein in renal cell carcinoma.
    Nguyen A; Jing Z; Mahoney PS; Davis R; Sikka SC; Agrawal KC; Abdel-Mageed AB
    Cancer Lett; 2000 Nov; 160(2):133-40. PubMed ID: 11053642
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metallothionein isoform 1 and 2 gene expression in the human bladder: evidence for upregulation of MT-1X mRNA in bladder cancer.
    Somji S; Sens MA; Lamm DL; Garrett SH; Sens DA
    Cancer Detect Prev; 2001; 25(1):62-75. PubMed ID: 11270423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isoform-specific expression of metallothionein mRNA in the developing and adult human kidney.
    Mididoddi S; McGuirt JP; Sens MA; Todd JH; Sens DA
    Toxicol Lett; 1996 Apr; 85(1):17-27. PubMed ID: 8619255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metallothionein 2A expression is associated with cell proliferation in breast cancer.
    Jin R; Chow VT; Tan PH; Dheen ST; Duan W; Bay BH
    Carcinogenesis; 2002 Jan; 23(1):81-6. PubMed ID: 11756227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metallothionein 1F and 2A overexpression predicts poor outcome of non-small cell lung cancer patients.
    Werynska B; Pula B; Muszczynska-Bernhard B; Gomulkiewicz A; Piotrowska A; Prus R; Podhorska-Okolow M; Jankowska R; Dziegiel P
    Exp Mol Pathol; 2013 Feb; 94(1):301-8. PubMed ID: 23064051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metallothionein isoform 1 and 2 gene expression in the human prostate: downregulation of MT-1X in advanced prostate cancer.
    Garrett SH; Sens MA; Shukla D; Flores L; Somji S; Todd JH; Sens DA
    Prostate; 2000 May; 43(2):125-35. PubMed ID: 10754528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metallothionein isoform 3 as a potential biomarker for human bladder cancer.
    Sens MA; Somji S; Lamm DL; Garrett SH; Slovinsky F; Todd JH; Sens DA
    Environ Health Perspect; 2000 May; 108(5):413-8. PubMed ID: 10811567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence of apoptosis and metallothionein expression in renal cell carcinoma.
    Zhang XH; Takenaka I
    Br J Urol; 1998 Jan; 81(1):9-13. PubMed ID: 9467469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metallothionein expression in renal cancer.
    Izawa JI; Moussa M; Cherian MG; Doig G; Chin JL
    Urology; 1998 Nov; 52(5):767-72. PubMed ID: 9801096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metallothionein 1F mRNA expression correlates with histological grade in breast carcinoma.
    Jin R; Bay BH; Chow VT; Tan PH
    Breast Cancer Res Treat; 2001 Apr; 66(3):265-72. PubMed ID: 11510698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Metallothionein isoforms gene expression induced by cadmium in human peripheral blood lymphocytes].
    Chang XL; Jin TY; Zhou YF
    Wei Sheng Yan Jiu; 2005 Mar; 34(2):137-40. PubMed ID: 15952643
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential expression of metallothionein 1 and 2 isoforms in breast cancer lines with different invasive potential: identification of a novel nonsilent metallothionein-1H mutant variant.
    Tai SK; Tan OJ; Chow VT; Jin R; Jones JL; Tan PH; Jayasurya A; Bay BH
    Am J Pathol; 2003 Nov; 163(5):2009-19. PubMed ID: 14578200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metallothionein 1 isoform gene expression induced by cadmium in human peripheral blood lymphocytes.
    Chang XL; Jin TY; Zhou YF
    Biomed Environ Sci; 2006 Apr; 19(2):104-9. PubMed ID: 16827180
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Post-transcriptional regulation of metallothionein isoform 1 and 2 expression in the human breast and the MCF-10A cell line.
    Gurel V; Sens DA; Somji S; Garrett SH; Weiland T; Sens MA
    Toxicol Sci; 2005 Jun; 85(2):906-15. PubMed ID: 15788722
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Significance of Fas expression alteration during tumor progression of renal cell carcinoma.
    Sejima T; Miyagawa I
    Int J Urol; 2006 Mar; 13(3):257-64. PubMed ID: 16643620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alteration of apoptotic regulatory molecules expression during carcinogenesis and tumor progression of renal cell carcinoma.
    Sejima T; Isoyama T; Miyagawa I
    Int J Urol; 2003 Sep; 10(9):476-84. PubMed ID: 12941126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Basal and copper-induced expression of metallothionein isoform 1,2 and 3 genes in epithelial cancer cells: The role of tumor suppressor p53.
    Ostrakhovitch EA; Song YP; Cherian MG
    J Trace Elem Med Biol; 2016 May; 35():18-29. PubMed ID: 27049123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An epigenetic screen unmasks metallothioneins as putative contributors to renal cell carcinogenesis.
    Alkamal I; Ikromov O; Tölle A; Fuller TF; Magheli A; Miller K; Krause H; Kempkensteffen C
    Urol Int; 2015; 94(1):99-110. PubMed ID: 24662736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metallothionein isoform expression by breast cancer cells.
    Barnes NL; Ackland ML; Cornish EJ
    Int J Biochem Cell Biol; 2000 Aug; 32(8):895-903. PubMed ID: 10940647
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Metallothionein and its isoform genes expression in the human pancreatic cancer cell strains and their function].
    Xie Y; Zhao YP; Chen G; Yuan CH; Li LJ
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2005 Oct; 27(5):619-23. PubMed ID: 16274045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.